These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3540081)

  • 21. Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.
    de Mey C; Enterling D; Meineke I; Yeulet S
    Br J Clin Pharmacol; 1991 Oct; 32(4):483-8. PubMed ID: 1683559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)].
    Bercovici JP; Khoury S; Tater D; Besson G; Caroff J
    Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
    Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
    Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.
    Cavagnini F; Benetti G; Invitti C; Ramella G; Pinto M; Lazza M; Dubini A; Marelli A; Müller EE
    J Clin Endocrinol Metab; 1980 Oct; 51(4):789-92. PubMed ID: 7419665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance.
    Ferrannini E; Pilo A
    J Clin Invest; 1979 Jul; 64(1):243-54. PubMed ID: 447855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-dose dopamine infusion on insulin and glucagon release in fasting normal man.
    Connell JM; Beastall GH; Davies DL; Buchanan K
    Horm Metab Res; 1986 Jan; 18(1):67-8. PubMed ID: 3512396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor blockade does not affect the natriuresis accompanying sodium chloride infusion in dogs.
    Bradley T; Gewertz BL; Scott WJ; Goldberg LI
    J Lab Clin Med; 1986 Jun; 107(6):525-8. PubMed ID: 2940307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats.
    Park S; Kang S; Lee HW; Ko BS
    Neuroendocrinology; 2012; 95(4):332-43. PubMed ID: 22441304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of altered prolactin secretion due to the administration of interleukin-1 beta into the brain ventricles of the rat.
    Rivier C
    Neuroendocrinology; 1995 Aug; 62(2):198-206. PubMed ID: 8584119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does endogenous dopamine modulate human sympathetic activity through DA2 receptors?
    Mannelli M; De Feo ML; Maggi M; Salvetti A; Giusti G; Serio M
    Eur J Clin Pharmacol; 1985; 29(2):159-64. PubMed ID: 2934264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of bromocriptine and domperidone on arginine-vasopressin response to insulin-induced hypoglycemia in normal men.
    Chiodera P; Coiro V
    Psychoneuroendocrinology; 1987; 12(3):225-30. PubMed ID: 3039562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion.
    Kaufman JM; Elewaut A; Vermeulen A
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
    Newman WP; Brodows RG
    J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of aging on growth hormone and prolactin release after growth hormone-releasing hormone and domperidone in man.
    Giusti M; Lomeo A; Marini G; Attanasio R; Barreca A; Camogliano L; Peluffo F; Giordano G
    Horm Res; 1987; 27(3):134-40. PubMed ID: 3121487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
    Pohl CR; Weiner RI; Smith MS
    Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion.
    Sgambato S; Passariello N; Paolisso G; Marano A; Buoninconti R; Tesauro P
    Acta Diabetol Lat; 1986; 23(1):13-22. PubMed ID: 3521178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.